Content Hub
RECENTLY ADDED!
2022 TPD Landscape Review
Beacon Targeted Therapies
Access this exclusive document to gain access to a deep review of the TPD landscape for 2022 including:
- 2021 Highlights
- The Current Landscape
- The Bivalent Degrader Landscape
- The Future of TPD
- Summary & Coming Up
TPD: A Promising Future
Beacon Targeted Therapies
An Interview with Jared Gollob,
MD, Chief Medical Officer, Kymera Therapeutics
Speaker at the 4th Targeted Protein Degradation Summit – October 2021
*Interview conducted October 2021
An Interview with Gwenn M. Hansen, Ph.D,
Chief Scientific Officer, Nurix Therapeutics
Speaker at the 4th Targeted Protein Degradation Summit – October 2021
*Interview conducted September 2021 - Gwenn’s comments reflect Nurix Therapeutics’ beliefs and assumptions as of the date of the interview
2020 Post-Event Report
Fill in the form for the full run-down on the 3rd Annual TPD Summit 2020 including key numbers, who attended, testimonials & more.
